全文获取类型
收费全文 | 53273篇 |
免费 | 3935篇 |
国内免费 | 218篇 |
专业分类
耳鼻咽喉 | 604篇 |
儿科学 | 1213篇 |
妇产科学 | 1122篇 |
基础医学 | 7562篇 |
口腔科学 | 1063篇 |
临床医学 | 5077篇 |
内科学 | 11031篇 |
皮肤病学 | 1253篇 |
神经病学 | 5148篇 |
特种医学 | 2136篇 |
外国民族医学 | 7篇 |
外科学 | 9404篇 |
综合类 | 517篇 |
一般理论 | 76篇 |
预防医学 | 2942篇 |
眼科学 | 1113篇 |
药学 | 3209篇 |
中国医学 | 76篇 |
肿瘤学 | 3873篇 |
出版年
2023年 | 499篇 |
2022年 | 984篇 |
2021年 | 1795篇 |
2020年 | 1073篇 |
2019年 | 1420篇 |
2018年 | 1613篇 |
2017年 | 1095篇 |
2016年 | 1302篇 |
2015年 | 1498篇 |
2014年 | 2026篇 |
2013年 | 2366篇 |
2012年 | 3807篇 |
2011年 | 3788篇 |
2010年 | 2094篇 |
2009年 | 1887篇 |
2008年 | 3008篇 |
2007年 | 3016篇 |
2006年 | 2844篇 |
2005年 | 2681篇 |
2004年 | 2464篇 |
2003年 | 2283篇 |
2002年 | 2072篇 |
2001年 | 751篇 |
2000年 | 724篇 |
1999年 | 716篇 |
1998年 | 508篇 |
1997年 | 407篇 |
1996年 | 307篇 |
1995年 | 278篇 |
1994年 | 254篇 |
1993年 | 247篇 |
1992年 | 467篇 |
1991年 | 426篇 |
1990年 | 392篇 |
1989年 | 346篇 |
1988年 | 346篇 |
1987年 | 324篇 |
1986年 | 305篇 |
1985年 | 317篇 |
1984年 | 261篇 |
1983年 | 243篇 |
1982年 | 200篇 |
1981年 | 187篇 |
1980年 | 195篇 |
1979年 | 234篇 |
1978年 | 180篇 |
1977年 | 164篇 |
1974年 | 183篇 |
1973年 | 157篇 |
1966年 | 154篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献
73.
74.
Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients 总被引:1,自引:0,他引:1
A. Åsberg A. Humar H. Rollag A. G. Jardine H. Mouas M. D. Pescovitz D. Sgarabotto M. Tuncer I. L. Noronha A. Hartmann 《American journal of transplantation》2007,7(9):2106-2113
Intravenous ganciclovir is the standard treatment for cytomegalovirus disease in solid organ transplant recipients. Oral valganciclovir is a more convenient alternative. In a randomized, international trial, recipients with cytomegalovirus disease were treated with either 900 mg oral valganciclovir or 5 mg/kg i.v. ganciclovir twice daily for 21 days, followed by 900 mg daily valganciclovir for 28 days. A total of 321 patients were evaluated (valganciclovir [n = 164]; i.v. ganciclovir [n = 157]). The success rate of viremia eradication at Day 21 was 45.1% for valganciclovir and 48.4% for ganciclovir (95% CI -14.0% to +8.0%), and at Day 49; 67.1% and 70.1%, respectively (p = NS). Treatment success, as assessed by investigators, was 77.4% versus 80.3% at Day 21 and 85.4% versus 84.1% at Day 49 (p = NS). Baseline viral loads were not different between groups and decreased exponentially with similar half-lives and median time to eradication (21 vs. 19 days, p = 0.076). Side-effects and discontinuations of assigned treatment (18 of 321 patients) were comparable. Oral valganciclovir shows comparable safety and is not inferior to i.v. ganciclovir for treatment of cytomegalovirus disease in organ transplant recipients and provides a simpler treatment strategy, but care should be taken in extrapolating to organ transplant recipients not properly represented in the present study. 相似文献
75.
76.
U. Bolm-Audorff S. Brandenburg T. Brüning H. Dupuis R. Ellegast G. Elsner K. Franz H. Grasshoff V. Grosser L. Hanisch B. Hartmann E. Hartung† K. G. Hering G. Heuchert M. Jäger J. Krämer Dr. A. Kranig E. Ludolph A. Luttmann A. Nienhaus W. Pieper K. D. Pöhl T. Remé D. Riede G. Rompe K. Schäfer S. Schilling E. Schmitt F. Schröter A. Seidler M. Spallek M. Weber 《Trauma und Berufskrankheit》2005,7(4):320-332
The first part of this serial paper dealt with the medical criteria used in evaluation of the clinical picture caused by physical stress and the evaluation of other candidate causes and was published in issue no. 3/2005 (pp. 711–752) of Trauma and Berufskrankheit. This follow-up paper (II) presents criteria to be used in the evaluation of whether it is necessary to give up the occupations putting the spine at risk and in estimation of the degree of disability. 相似文献
77.
78.
Gregory J. Pomper Rita A. Joseph Erica L. Hartmann Michael S. Rohr Patricia L. Adams Robert J. Stratta 《American journal of transplantation》2005,5(10):2586-2589
Massive immune hemolysis due to passenger lymphocyte-derived anti-D has not been reported in renal transplantation. A 50-year-old (B-positive) male received a dual deceased-donor kidney transplant (B-negative) for diabetic renal failure. Two weeks post-transplant, the patient developed severe hemolytic anemia. The donor anti-D titer was 1:8. The recipient anti-D titer (zero pre-transplant) increased from 1:4 to 1:16 over 4 days. Rapid hemolysis caused severe anemia, minimum Hb = 4.2 g/dL, while selectively lysing the patient's autologous red cells during this time. The hemolytic anemia did not impair the allografts and subsided without monoclonal B-cell pharmacotherapy or apheresis. The anti-D titer decreased to barely detectable levels at four months and had cleared when checked 2 years post-transplant. Transfusion support subsided after two months. If complications of anemia can be avoided, the deleterious effects of hemolysis may be well tolerated by renal allografts using antigen negative transfusion alone. 相似文献
79.
In Vivo Molecular Imaging Characterizes Pulmonary Gene Expression During Experimental Lung Transplantation 总被引:2,自引:0,他引:2
Sekhar Dharmarajan Makio Hayama James Kozlowski Takaaki Ishiyama Mikio Okazaki Phillip Factor G. Alexander Patterson Daniel P. Schuster 《American journal of transplantation》2005,5(6):1216-1225
Experimental gene therapy is a promising strategy to prevent ischemia-reperfusion (I/R) injury and allograft rejection after lung transplantation, and methods will eventually be needed to characterize pulmonary transgene expression in vivo in humans. Therefore, we studied positron emission tomography (PET) as a means of performing in vivo molecular imaging in rodent models of lung transplantation. Rats were transfected endotracheally with adenovirus encoding a fusion gene of a mutant Herpes simplex virus-1 thymidine kinase and the green fluorescent protein gene (the former serving as an imaging reporter gene). Twenty-four hours after transfection, lungs were transplanted in groups representing normal transplantation, I/R injury and acute allograft rejection. Imaging was obtained either 24 h after transplantation to study reperfusion injury or 4 days after transplantation to study graft rejection. After imaging, lungs were excised and analyzed for thymidine kinase activity. Imaging detected transgene expression in transplanted lungs even in the presence of acute rejection or I/R injury. The PET imaging signal correlated with in vitro lung tissue assays of thymidine kinase activity (r(2) = 0.534). Thus, noninvasive molecular imaging with PET is a feasible, sensitive and quantitative method for characterizing pulmonary transgene expression in experimental lung transplantation. 相似文献
80.
Margaret J Bowers Nick J Orr Si Dempsey H Denis Alexander 《Blood coagulation & fibrinolysis》2006,17(5):409-411
We present a case of Bernard Soulier syndrome in a 9-year-old boy caused by a novel genetic mutation. This child was shown to be homozygous for a single nucleotide deletion (c.1077delG) in the GP1BA gene not previously reported. Clinically, the boy has become refractory to platelet transfusions with both allo-antibodies and iso-antibodies and a massive transfusion requirement for ongoing haemorrhage. We describe the critical role that the blood product transfusion continues to play in the management of Bernard Soulier syndrome and discuss therapeutic options in these patients. 相似文献